HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ryo Kobayashi Selected Research

Neutropenia

11/2023Prognostic impact of severe neutropenia in colorectal cancer patients treated with TAS-102 and bevacizumab, addressing immortal-time bias.
11/2018Severe Neutropenia is Associated with Better Clinical Outcomes in Patients with Advanced Pancreatic Cancer Who Receive Modified FOLFIRINOX Therapy.
1/2014Pharmacotherapy for adverse events reduces the length of hospital stay in patients admitted to otolaryngology ward: a single arm intervention study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ryo Kobayashi Research Topics

Disease

18Neoplasms (Cancer)
01/2024 - 04/2008
8Infections
01/2024 - 01/2011
8Colorectal Neoplasms (Colorectal Cancer)
11/2023 - 06/2016
8Vomiting
05/2023 - 01/2014
8Nausea
05/2023 - 01/2014
6Stomatitis
01/2021 - 01/2014
4Stomach Neoplasms (Stomach Cancer)
09/2022 - 12/2017
4Pain (Aches)
08/2021 - 12/2014
3COVID-19
01/2024 - 09/2022
3Peripheral Nervous System Diseases (PNS Diseases)
01/2024 - 08/2021
3Neutropenia
11/2023 - 01/2014
3Pancreatic Neoplasms (Pancreatic Cancer)
08/2021 - 11/2018
3Head and Neck Neoplasms (Head and Neck Cancer)
01/2016 - 04/2008
2Cachexia
04/2022 - 12/2020
2Hemorrhage
01/2022 - 01/2018
2Breast Neoplasms (Breast Cancer)
05/2021 - 01/2018
2Adenocarcinoma
05/2021 - 09/2011
2Neoplasm Metastasis (Metastasis)
05/2021 - 12/2016
2Hematologic Neoplasms (Hematological Malignancy)
08/2018 - 12/2014
2Constipation
01/2017 - 01/2014
2Anaphylaxis (Anaphylactic Shock)
01/2012 - 10/2010
2Appendicitis
11/2011 - 02/2010
1Hyperalgesia
01/2024
1Cardiovascular Diseases (Cardiovascular Disease)
12/2023
1Autoimmune Diseases (Autoimmune Disease)
12/2023
1Diabetes Mellitus
10/2023
1Periodontitis
06/2023
1Internal Hernia
05/2023
1Rectal Neoplasms (Rectal Cancer)
05/2023
1Hernia (Hernias)
05/2023
1Abdominal Pain (Pain, Abdominal)
05/2023
1Sleepiness
03/2023
1Fever (Fevers)
01/2023
1Liver Diseases (Liver Disease)
01/2023
1Human Influenza (Influenza)
07/2022
1Uterine Cervical Neoplasms (Cancer of the Cervix)
06/2022
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2022
1Fistula
02/2022
1Empyema
02/2022
1Glycogen Storage Disease (Glycogenosis)
01/2022
1Wounds and Injuries (Trauma)
01/2022
1Cellulitis
01/2022
1Anorexia
08/2021
1Hyperammonemia
08/2021
1Chronic Renal Insufficiency
08/2021

Drug/Important Bio-Agent (IBA)

7AntiemeticsIBA
05/2023 - 12/2016
5Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2024 - 12/2016
5polaprezinc (Z 103)IBA
01/2021 - 12/2014
4AlginatesIBA
08/2018 - 12/2014
4SuspensionsIBA
08/2018 - 12/2014
3AntibodiesIBA
01/2024 - 01/2011
3Antineoplastic Agents (Antineoplastics)IBA
12/2023 - 04/2022
3Bevacizumab (Avastin)FDA Link
11/2023 - 01/2021
3AntigensIBA
01/2018 - 10/2010
2Proteins (Proteins, Gene)FDA Link
01/2024 - 04/2008
2PlatinumIBA
01/2024 - 03/2023
2trifluridine tipiracil drug combinationIBA
11/2023 - 05/2023
2Serotonin (5 Hydroxytryptamine)IBA
03/2023 - 06/2022
2AlbuminsIBA
01/2023 - 07/2021
2Cisplatin (Platino)FDA LinkGeneric
06/2022 - 12/2017
2Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2021
2Syndecan-1 (Syndecan 1)IBA
01/2022 - 01/2021
2BilirubinIBA
07/2021 - 11/2018
2Irinotecan (Camptosar)FDA LinkGeneric
11/2018 - 12/2016
2azuleneIBA
08/2018 - 12/2014
2Olanzapine (Zyprexa)FDA Link
01/2018 - 12/2017
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2018 - 01/2017
2EmeticsIBA
12/2017 - 12/2016
2Immunoglobulin E (IgE)IBA
01/2012 - 10/2010
1nafamostatIBA
01/2024
1Protective AgentsIBA
01/2024
1LDL CholesterolIBA
12/2023
1Immunosuppressive Agents (Immunosuppressants)IBA
12/2023
1Mirtazapine (Rexer)FDA LinkGeneric
03/2023
1Histamine H1 Receptors (Histamine H1 Receptor)IBA
03/2023
1C-Reactive ProteinIBA
01/2023
1Indicators and Reagents (Reagents)IBA
09/2022
1Neutralizing AntibodiesIBA
09/2022
1Immunoglobulin G (IgG)IBA
09/2022
1Paclitaxel (Taxol)FDA LinkGeneric
09/2022
1Immunoglobulin M (IgM)IBA
09/2022
1SilverIBA
07/2022
1Neurokinin-1 Receptor AntagonistsIBA
06/2022
1Dexamethasone (Maxidex)FDA LinkGeneric
06/2022
1pembrolizumabIBA
04/2022
1Branched-Chain Amino AcidsIBA
08/2021

Therapy/Procedure

21Drug Therapy (Chemotherapy)
11/2023 - 12/2014
12Therapeutics
06/2023 - 02/2010
5Radiotherapy
06/2022 - 12/2014
4Hematopoietic Stem Cell Transplantation
01/2021 - 12/2014
2Sutures (Suture)
05/2023 - 02/2022
2Combination Drug Therapy (Combination Chemotherapy)
05/2023 - 07/2021
2Length of Stay
07/2018 - 01/2014
1Polypharmacy
10/2023
1Proctectomy
05/2023
1Colostomy
05/2023
1Injections
01/2023
1Negative-Pressure Wound Therapy
02/2022
1Thoracostomy
02/2022
1Gastrostomy
01/2022